Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Top patient safety concerns of 2020

Missed and delayed diagnosis is the top patient safety concern of 2020, according to a new list from ECRI.

Thumbnail

Patients are comfortable with AI-powered cancer screening, but still want input from physicians

Patients are on board with AI-powered skin cancer screening, according to a new study published in JAMA Dermatology. But relationships with human physicians remain a priority.

Thumbnail

Trump sends drug pricing reform principles to Congress

President Trump has sent his wish list of drug pricing reform priorities to Capitol Hill.

Thumbnail

Imaging specialists raise $11M for AI-powered lung disease detection

VIDA Diagnostics, a Coralville, Iowa-based imaging technology company, has announced the completion of a Series C financing round worth $11 million.

Thumbnail

Industry reactions to interoperability rule are a mixed bag

A set of new rules that aim to improve the interoperability of healthcare records and set a string of new requirements on healthcare providers was met with mixed reactions across the industry.

Thumbnail

Microsoft signs deal to sell AI-powered blood tests for CVD

Microsoft has signed a new deal with Prevencio, a cardiovascular health company based in Kirkland, Washington, to market and sell AI-powered cardiac blood tests to the public.

Thumbnail

Coronavirus is a global pandemic, says World Health Organization

The World Health Organization has declared the new coronavirus, COVID-19, a pandemic and urged countries to take serious steps to mitigate further spread of the disease.

Thumbnail

Non-US citizens less likely to receive treatment for CV ills

U.S.-born and -naturalized citizens are far more likely than noncitizens to receive treatment for CVD risk factors, researchers reported in Circulation this month.

Displaying 2009 - 2016 of 6649

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup